TuHURA BIOSCIENCES, INC./NV Operating Costs and Expenses
TuHURA BIOSCIENCES, INC./NV (HURA) reported Operating Costs and Expenses of $3.13 thousand for the 3-month period ending 2012-03-31, per its 10-Q/A filed 2012-06-05.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OperatingCostsAndExpenses · last filed 2012-06-05
- TuHURA BIOSCIENCES, INC./NV operating costs and expenses for the quarter ending 2012-03-31 was $3.13K, a 18.24% decline year-over-year.
- TuHURA BIOSCIENCES, INC./NV operating costs and expenses for the quarter ending 2011-03-31 was $3.83K.
| Period end | Operating Costs and Expenses 3 month | Operating Costs and Expenses 9 month | Operating Costs and Expenses 33 month |
|---|---|---|---|
| 2012-03-31 | $3.13K 10-Q/A · filed 2012-06-05 | $17.90K 10-Q/A · filed 2012-06-05 | $56.62K 10-Q/A · filed 2012-06-05 |
| 2011-03-31 | $3.83K 10-Q/A · filed 2012-06-05 | $26.30K 10-Q/A · filed 2012-06-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |